Showing results (1651-1660 of 2,033) with videos related to

Sort By:
Pageof 204
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2013
Transient photoreceptor deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsiaAndrás M Komáromy, Jessica S Rowlan, Amanda T Parton Corr, et al.
American Journal of Nephrology|August 31, 2011
Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in manMelinda T Coughlan, Sheila K Patel, George Jerums, et al.
Plos One|October 14, 2016
A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 ActivationJason D Marshall, Darren S Heeke, Eileen Rao, et al.
Antioxidants & Redox Signaling|September 24, 2013
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathyJennifer L Wilkinson-Berka, Devy Deliyanti, Indrajeetsinh Rana, et al.
Nutrients|November 11, 2022
Development and Validation of an Eating-Related Eco-Concern QuestionnaireBaiyu Qi, Emily K Presseller, Gabrielle E Cooper, et al.
Renal Failure|February 21, 2022
Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetesLijun Zhao, Qianqian Han, Li Zhou, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathyJosephine M Forbes, Suzanne R Thorpe, Vicki Thallas-Bonke, et al.
Journal of Hypertension|February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthaseAino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Diabetologia|December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout miceA M D Watson, A Soro-Paavonen, K Sheehy, et al.
Pageof 204